Weekly Market Roundup
Quantinuum Lists on Nasdaq as Quantum Computing Hits Three Milestones in One Week
Quantum computing had its biggest week as a public market story. Quantinuum debuted on Nasdaq at $60 per share, pricing above its target range and raising $1.68 billion. D-Wave, which has spent its entire existence building annealing systems, announced a roadmap to 100 logical qubits using gate-model hardware. And IonQ published a paper demonstrating quantum…
Three Cancer Drug Programs Advanced This Week and Nobody Noticed
MAIA Biotechnology got FDA clearance to open US enrollment for its Phase 2 lung cancer trial on June 3. ADC Therapeutics released Phase 3 data confirming ZYNLONTA extends progression-free survival in lymphoma the same day. Verastem got an FDA Fast Track for its KRAS G12D inhibitor in lung cancer the day after. Three different companies,…
Three Crypto Fintech Stories That Changed the Market This Week
Three developments in four days made the US crypto and fintech landscape structurally different. On May 27, SoFi put a bank-issued stablecoin in 14.7 million people’s banking apps — the first time a federally chartered US bank has done that. On May 29, the CFTC opened regulated perpetual futures to US traders for the first…
NeoVolta Signs $200M Battery LOI as TeraWulf Buys Kentucky Power
The AI power crunch is producing two kinds of energy stories right now. Companies building the physical supply of batteries and power infrastructure to fill the gap, and companies racing to lock in the energy-advantaged sites before they are gone. Both happened this week. NeoVolta signs its first utility-scale LOI — $200 million, 1.1 GWh,…
BigBear.ai Deploys at Panama Port, Hadron Energy Lists on Nasdaq, SoundHound Acquires LivePerson
Computex 2026 ran May 26-30 in Taipei. Jensen Huang showed up with 150 ecosystem partners, laid out the Vera Rubin and Grace Blackwell roadmap, and teased a surprise product for the second half of the year that nobody has seen yet. Intel showed rackscale AI infrastructure. The headline announcements were all large cap. The same…
Ivonescimab posted a 34% survival benefit at ASCO — the FDA decides in November
ASCO week closed with one result that changed the conversation about lung cancer. Ivonescimab cut the risk of death by 34% in squamous NSCLC. The data landed in a Plenary Session. It was published simultaneously in The Lancet. It was the first time in the 61-year history of ASCO that a China-originated drug has been…
Crypto Weekly: DMG Blockchain Targets Sovereign AI While Sol Strategies Expands
Canadian blockchain companies spent the last two years mining Bitcoin and staking Solana. Now they are repurposing that infrastructure for something else entirely. One is building cross-chain privacy routing on top of its validator network. One is converting its British Columbia mining facility into a government-grade AI data center. A third is quietly accumulating Bitcoin…
Green Energy Weekly: NeoVolta, T1 Energy and Greenbriar Post Cleantech Milestones
The domestic clean energy manufacturing push is not waiting for Washington to sort itself out. It is happening now, largely out of the headlines, driven by companies most investors have never looked at. This week three of them had news worth knowing about. Battery storage costs have fallen 93% since 2010. US operating storage capacity…










